The present invention refers to a device in connection with an inhaler intended for measuring and recording the course of inhalation of a patient. The device is intended for use in medication, e.g. clinical tests, where there is a need of afterwards being able to control if the patient has taken medicine in a prescribed way. The device comprises an electronic unit provided in the inhaler for recording of the time for each dosage of the medicine of the inhaler. A detector (16,32,36) is provided in the inhaler in connection with a passage for the airflow of inhalation, whereby the detector detects the airflow of the inhalation through the inhaler as well as the availability of the medicine at the inhalation within said passage, so that a combination of these two detected values decides if and how the performed inhalation should be recorded in the electronical unit (11,33,35).

Patent
   5331953
Priority
Mar 07 1989
Filed
Jul 06 1993
Issued
Jul 26 1994
Expiry
Jul 26 2011
Assg.orig
Entity
Large
272
12
all paid
1. A portable inhaler device including medication storage means and including a passage through which inhalation air flows, said device having dispensing means for dispensing medication into said passage, said device comprising:
a single detector means disposed in said passage for detecting air flow as well as the availability of medication dispensed into said passage for inhalation and for generating electrical signals responsive thereto; and
electronic means disposed in said device for recording the inhalation of medication responsive to predetermined values of said signals indicating adequate inhalation of medication in a prescribed manner to permit periodic determination of whether a prescribed dosage of medicine has been effected.
10. A method of dispensing medication; said method comprising the steps of; providing a portable inhaler device having dispensing means for making medication available for inhalation and a passage through which inhalation air flows, comprising the steps of providing a single detector within said passage:
detecting within said detector the availability of a medicine dose and generating a first electrical signal responsive thereto;
detecting with said detector the inhalation flow through the passage and generating a second electrical signal responsive thereto;
providing said first and second electronic signals to a processor contained in said device;
determining, responsive to said first and second electronic signals, if and how the performed medication shall be recorded; and
recording the inhalation in a storage means contained in said device responsive to predetermined values of said signals.
2. A device according to claim 1, wherein said dispensing means includes means for feeding of a medicine dose, and wherein said detector means comprises a sound detector for detecting the sound of feeding of a medicine dose as well as a sound arising at inhalation through said passage.
3. A device according to claim 2, wherein said sound detector comprises a microphone.
4. A device according to claim 2, comprising means including a schmitt trigger for converting signals from said sound detector to binary signals of approved and not approved inhalation, respectively.
5. A device according to claim 2, including an inhalation channel and comprising further a turnable dosage disc with dosage holes for dispensing powder, and means for rotating said disk step by step for moving successive doses to said inhalation channel, wherein said sound detector is arranged to detect sound produced by rotation of said dosage disc.
6. A device according to claim 5, including an air intake, and an air channel between said air intake and the dosage disc, wherein the sound detector is arranged close to said air channel for detecting the noise arising in the air channel at the inhalation.
7. A device according to claim 1, comprising an aerosol dispensing means, wherein the detector means comprises a pressure transmitter means for detecting a subpressure in said passage during inhalation as well as a momentary pressure change arising at the release of an aerosol dose.
8. A device according to claim 1, wherein said electronic means includes microprocessor means for receiving signals from said detector means, and readable memory unit means for storing signals from said microprocessor means.
9. A device according to claim 8, comprising a battery arranged to provide said electronic means with power, a removable protective cover having a metal ring, a pair of contacts which are positioned to be short circuited by the metal ring when the cover is in place, and circuit means for disconnecting power to said electronic means when said contacts are short circuited.
11. A method according to claim 10, further comprising the step wherein the processor determines, responsive to the detected signals, whether the medication takes place in an approved way, and the step of recording the time of an approved medication in a memory unit.

This application is a continuation of application Ser. No. 07/603,686, filed on Jan. 7, 1991.

The present invention relates to a device in connection with an inhaler intended for measuring and recording of the inhalation course of a patient. The device is intended for use in medical treatment, e.g. in clinical tests, where there is a need for recording a course of events afterwards in order to be able to verify if the patient has taken medicine in the prescribed way. The device can also be used to detect the level of trouble of the patient between the patient's visits to a doctor.

The omission of a patient to keep up to a medication prescribed by a doctor might be the reason for an unsuccessful treatment e.g. for cronical deseases. With a desease as e.g. asthma, where a continous medication program is necessary, it is especially important that the medication is performed in a prescribed way. Investigations have proven that between 30 and 50% of the patients take medicines irregularly and incorrect when they take the medicines themselves, which fact often is not discovered by the doctor in charge. The difficulty of recording how well the patient follows the prescriptions for the medication results in an unsatisfactory security in the evaluation of clinical tests.

One type of control systems for the medication of patients, used today, the so called MEMS® system, comprises different types of ordinary standard medicines containers, which are provided with microprocessors, which record date and moment for each opening and closing of the containers.

Another known control system, called Nebulizer Chronolog®, consists of a small portable device, in which is contained a standard aerosol container. At each release of an aerosol dose, a contact device is actuated, whereby an electronical memory unit stores date and moment for each dosage fed out.

For a patient inhaling his medicine to receive an acceptable dosage to the lungs, however, it is necessary that the release of an aerosol dosage is coordinated with the inhalation of the patient. When using a powder inhaler device, the inhalation flow must reach a "critical flow" to make the powder dose follow the airflow and for the formation of a favourable particle picture, which can reach far enough down into the lungs.

The above disclosed known systems used today record the moment for each event when a medicine package is opened or each time a medicine dose is released, but these known systems lack the possibility of detecting if and when a satisfactory medication has been performed of the patient. With these systems one has not been able to receive a confirmation of that the patient really takes his dose and that the patient takes his dose in the prescribed way in order to get a medical effect.

The object of the present invention is to solve the above problems by a device in connection with an inhaler, which can measure and record if and when a satisfactory medication has been performed in a patient.

A device of the kind discussed in the beginning is according to the invention characterized in that a detector is provided in the inhaler in connection with a passage for the inhalation air-flow, whereby the detector is arranged to detect the inhalation airflow through the inhaler as well as the accessibility of the medicine at the inhalation, whereby the combination of the detected values determines if and when the inhalation should be recorded in the electronical unit.

Further advantageous features of the invention will be evident from the following description of embodiments and the sub-claims.

A change of sound or pressure occurring at the feeding of a powder dose, at the release of a pressure aerosol or at the punctuation of a powder capsule can be detected by a detector and the generated signal can subsequently be treated and recorded by the components in an electronical unit. A characteristic back noice or a pressure drop, which occurs in the inhaler at inhalation can be detected by the detector and can thereafter be treated and recorded by the electronical unit.

In order to obtain a satisfactory picture of how a patient has performed a planned medication with the aid of an inhaler, it is thus important to be able to detect the patient's own inhalation in combination with a detection of the availability of the medicine dose for the patient. In certain cases it is also important to be able to read how the course of the inhalation looks, that is how strong and how long it is, in order to be able thereby to determine if the inhalation of the patient has enough strength and duration for the obtaining of a correct deposition of active substance in the lungs.

The device according to the invention is also suitable for use in measuring and recording the level of severity of a patient's sickness state in periods between the patient's visits to a doctor. By the recording of different inhalation parameters, which correlates to the severity of the asthma desease, with the aid of the device according to the invention, the doctor can get a good picture of the development of the patient's desease during the time between the medical examinations.

The detector can be comprised of a sound detector, e.g. a microphone of the type electret microphone, but also other types of detectors, such as for example a pressure transmitter, are feasible within the scope of the invention.

One embodiment of the device according to the present invention and modifications thereof are described more in detail below with reference to the accompanying drawings, wherein

FIG. 1 shows an exploded view of a powder inhaler wherein the airflow through the inhaler is marked with arrows,

FIG. 2 shows a cross-sectional view through a powder inhaler according to FIG. 1 with a device for measuring and recording sound according to the invention,

FIGS. 3a and 3b show two alternative block diagrams of comprised electronical components in FIG. 2,

FIG. 4 shows a diagram of how the microphone in FIG. 2 catches outside, disturbing noise,

FIG. 5 shows a diagram of how the microphone in FIG. 2 catches inhalation noise through the inhaler,

FIG. 6 shows a diagram of the measuring signal of the inhalation after passage through filter and amplifier,

FIG. 7 shows a cross sectional view through a dose aerosol with a device according to the invention, and

FIG. 8 shows a cross sectional view through a powder inhaler for gelatine capsules with a device according to the invention.

In FIG. 1 an exploded view of a powder inhaler is shown, which is driven by the patient's own breath. The airflow through the inhaler at the inhalation is marked by arrows A.

FIGS. 1 and 2 show the different parts of the powder inhaler. A pivotable control unit 1 with double grip rings 2 cooperates with a dosage unit 3, which, when the operating unit 1 is turned, feeds a powder dose to an inhalation channel 4. The active substance is kept in a substance container 5. A mouthpiece 6 is provided with an insert with narrow helical deflection devices 7 for decomposition of the substance powder into an inhalatable powder fraction. The dosage unit 3 is shaped as a flat, rotatable disc with groups of dosage holes 8 and the disc is arranged at the bottom of the substance container 5. The dosage holes 8 are filled with substance in the position below the substance container 5. When the grip rings 2 are turned and fed one step forward the dosage disc 3 is brought therewith in the rotation. A number of scrapers 9 are arranged to abut the dosage disc 3, whereby the scrapers remove excess powder substance above the dosage holes 8 at the turning of the dosage disc 3.

When the patient inhales from the mouthpiece opening, air flows through two opposite air inlets 10 in the operating unit 1 and through the group of dosage holes 8, which at the moment are exposed at the inhalation channel 4 situated above the dosage disc 3, further through the channel 4 and out through the mouthpiece 6. When the airflow passes the dosage holes 8 the dose of active substance loaded in the holes will be released and will be brought further on together with the air flow and will be decomposed in the helical passage in the mouthpiece 6.

Inside the two separable grip rings 2 of the operating unit an electronical unit 11 with a battery 12 as the source of voltage is arranged. Two contact surfaces 13 are arranged on the upper and outer side of the upper grip ring 2. When the inhaler is not used, a protective cover 14 is put over the mouthpiece 6 of the inhaler and down over the air intakes 10, whereby the protective cover 14 with its lower edge abuts the upper side of the upper grip ring 2. The lower edge of the protective cover 14 is provided with a metal contact ring 15. The contact ring 15 abuts the two contact surfaces 13 on the grip ring 2 when the protective cover 14 is put on, whereby the two contact surfaces 13 get electrical contact. A microphone 16 is arranged in direct connection with an air channel 17 between the air intakes 10 and the dosage disc 3 and the microphone is connected to the electronical unit 11 inside the operating unit 1. The microphone 16 can alternatively be placed in connection with the air channel, but separated from this through a thin diaphragm.

The electronical unit is explained more in detail with reference to the block diagram in FIG. 3a. The microphone 16 detects the sound of the "click", which occurs upon turning forward of a new dose and the sound of the airflow at an inhalation, and transfers these signals. A band pass filter 18 separates one for the inhalation typical and suitable working frequency (see FIG. 5). An amplifier 19 lifts up the signal level from the microphone 16, which leaves signals of the order of a few millivolts and the signals will here be amplified to about 1 V. The signal is rectified and is low pass filtered in a detector 20 so that the envelope of the signal is obtained. The envelope signal is a measure of the momentary air flow. A Schmitt trigger 21 quantitizes the signal and leaves the values "approved" and "not approved", respectively. The signal of the microphone is here transformed to a binary signal which states if the strength of the inhalation is sufficient. The hysteres of the Schmitt trigger makes that small variations in flow will not make the signal flutter between "approved" and "not approved".

With the need of more than two quantitizing leves (approved/not approved) the Schmitt trigger 21 might be replaced by an analogue-digital-converter (A/D converter) 22, which is shown in FIG. 3b, the function of which is to measure the airflow one or several times during the inhalation. These results are stored together with a time notation in a memory 23 for further treatment.

The microphone signal, which is generated by the sound of the forward turning, is rectified in a detector 24 so that the absolute value of the signal is obtained. An amplifier 25 lifts the level of the signal from the microphone 16 to an order of about 1 V. This signal passes a puls stretcher 26, which stretches the short, transient "click" sound to a signal with logical levels and a sufficient duration for a processor to record it.

The processor 27 shall keep track of actual time, i.e. be a clock, collect the treated signals from the microphone and through these signals check that the patient takes his dosage in the prescribed way. The prescribed way means that the patient shall turn forward a dose and breath with a sufficient flow and sufficient duration in order to obtain an effective deposition in the lungs. The processor 27 performs the measurement of the length of the inhalation and transfers the time for an approved inhalation to the memory unit 23. The processor 27 also detects if the contact surfaces are short circuited, that is if the protective cover 14 is put on, and takes care of the communication with a reading unit, which reads the gathered information in the memory unit 23. The processor 27 supplies the band pass filter 18, the amplifier 19, the detector 20 and the Schmitt trigger 21 with power only when the protective cover 14 is not put on in order to save the battery 12 in this way.

The memory unit 23 is suitably comprised of an EPROM (Electrically Eraseably Programmable Read Only Memory), which is an electrically eraseable, fixed memory. An EPROM is preferably used here since the information must not be lost if the battery should be finished. In this memory the times of inhalation is saved for approved inhalations and optional inhalation measurement test results.

FIG. 4 shows a diagram of how disturbing noise from the outside, in this case music from the radio at an extremely high sound level, is captured by the microphone 16 inside the powder inhaler according to FIG. 2.

FIG. 5 shows the corresponding diagram of how the microphone 16 reacts to the airflow through the inhaler at the inhalation. The lower graph shows a sound spectrum for an airflow of 10 l/min, and the other graphs, in the upward direction, show the corresponding sound spectra for 20 l/min, 30 l/min and 60 l/min, respectively. The measuring range which is of interest for the air-flow lies in the range of between 20 l/min and 100 l/min. Since the measurements should be insensitive for outside noise disturbances it is evident from the graphs in FIGS. 4 and 5 that a signal at the frequency of 9 kHz is a suitable measuring signal in this embodiment.

FIG. 6 shows the size of the measuring signal in Volts after filter and amplifier at inhalation flows from 20 l/min to 80 l/min.

When the patient shall medicate with the aid of the described powder inhaler, first he takes off the protective cover 14, whereby the contact ring 15 at the lower edge of the cover breaks the contact with the two contact surfaces 13 in the upper side of the upper grip ring 2, whereby the voltage to the band pass filter 18, the amplifier 19, the detector 20 and the Schmitt trigger 21 are connected. A dosage of active substance is fed forward to the inhalation channel 4 by turning the grip ring 2 forward one step. This turning forward creates a "clicking" sound which is detected by the microphone 16. When the turning forward is recorded by the processor 27 in the electronical unit the microphone 16 "listens" for the noise arising when the patient inhales through the inhaler and thereby inhales the dosage fed forward. Since the noise has a characteristic segment, only noise at this frequency is amplified by the amplifier 19. The signal after the amplifier is quantitized in two steps, insufficient flow or sufficient flow. Alternatively the signal can be measured at several levels with optional grading. When an approved inhalation is detected, the time for the inhalation is stored in the memory 23 and in the alternative case also the "value" of the inhalation is stored.

At the next coming visit to the doctor, the doctor can, by separating the two grip rings 2, get access to the electronical unit and read the memory 23 using a special reading equipment, which is connected to the electronical unit. This reading equipment reads the approved inhalation times and transfers the information to a computer, which can process and present the material in a way suitable for the doctor. In the alternative with quantitizing in more than two levels the "value" of the inhalation is also read, which can be presented as a flow/time diagram or as an inhalation measure, e.g. peak inspiratory flow, PIF of total volume (VC).

In FIG. 7 is shown a dose aerosol with pressure filled canister. The pressure canister 28 is provided with a nozzle 29 and is placed in a bracket 30 with a nozzle 31. The bracket 30 is shaped with a separable unit, which comprises a detector 32 in connection with the air channel for the inhalation flow and an electronical unit 33. When the patient inhales from the mouthpiece opening air flows past the gap around the pressure canister 28 and out through the mouthpiece 31.

In order to obtain perfect medication effect with a dose aerosol the patient shall, during the introductory phase of the inhalation, press the canister 28 down so that a dose is released through the nozzle 29. The air flow around the canister 28 and the bracket 30 give rise to a noise, which can be detected by a noise detector 32. When a dosage is released through the nozzle a sound arises, which can be distinguished from the noise and can be detected by the detector. Since these sounds are different from each other, a microphone can be used as detector also in this embodiment.

At inhalation through the inhaler according to FIG. 7 a pressure drop is created between the ambient pressure and the pressure at the mouthpiece opening, i.e. a sub-pressure arises inside the bracket 30 when the patient inhales, which sub-pressure can be detected by a pressure transmitter. At the release of a dose a strong pressure change with short duration arises, which is also detectable by a pressure transmitter. In the embodiment according to FIG. 7 thus also a pressure transmitter can be used for detection of both the inhalation and the release of a dose, i.e. the information necessary for controlling that the patient uses the dose aerosol in the prescribed way.

FIG. 8 shows a powder inhaler, which is loaded with a gelatine capsule 34 with powder substance. An electronical unit 35 with detector 36, preferably a microphone, works in a similar way as the powder inhaler shown in FIG. 2. When a capsule is placed in the inhaler it is punctuated/broken by needles 37 brought through the wall of the capsule. When the capsule has been punctuated/broken the substance will be available for the inhalation flow. The punctuation/braking of the capsule causes a short and intensive sound which is detected by the microphone 36. At inhalation here also arises a characteristic sound which is detected/measured in the same way as in the other embodiments.

The device according to the invention is also suitable for use in an inhalator with rotating parts, e.g. of the type Rotacaps® in that instead of measuring the level of the sound one measures the dominating frequency of the rotation sound. The recorded frequency images and can be transformed into a measure of the airflow through the inhaler.

In order to simplify the reading of the memory, any type of external computer contact might be arranged in the cover of the inhaler, thereby being accessible for reading without any need of demounting the inhaler.

Nilsson, Nils G., Andersson, Jan A. R., Fagerstrom, Per-Olof S., Wendel, Thomas M.

Patent Priority Assignee Title
10002517, Aug 28 2013 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
10029056, Aug 29 2012 Royal College of Surgeons in Ireland System and method for monitoring use of a device
10084880, Nov 04 2013 Proteus Digital Health, Inc. Social media networking based on physiologic information
10130581, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
10130685, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
10130709, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
10143655, Sep 14 2005 MannKind Corporation Method of drug formulation
10159644, Oct 26 2012 MannKind Corporation; TechnoVax, Inc. Inhalable vaccine compositions and methods
10172850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
10172853, Feb 11 2007 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
10175376, Mar 15 2013 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
10187121, Jul 22 2016 OTSUKA PHARMACEUTICAL CO , LTD Electromagnetic sensing and detection of ingestible event markers
10188614, May 03 2002 Nektar Therapeutics Particulate materials
10201672, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
10207093, Apr 07 2010 Proteus Digital Health, Inc. Miniature ingestible device
10251881, Apr 17 2002 Nektar Therapeutics Particulate materials
10258664, Oct 24 2011 MannKind Corporation Methods and compositions for treating pain
10307464, Mar 27 2015 MannKind Corporation Use of ultrarapid acting insulin
10342938, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
10375990, Oct 19 2012 Nicoventures Trading Limited Electronic inhalation device
10376218, Feb 01 2010 Proteus Digital Health, Inc. Data gathering system
10398161, Jan 21 2014 OTSUKA PHARMACEUTICAL CO , LTD Masticable ingestible product and communication system therefor
10421658, Aug 30 2013 OTSUKA PHARMACEUTICAL CO , LTD Container with electronically controlled interlock
10421729, Mar 15 2013 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
10440517, Sep 28 2015 Nicoventures Trading Limited Vaping heat map system and method for electronic vapor provision systems
10456536, Mar 25 2014 KONINKLIJKE PHILIPS N V Inhaler with two microphones for detection of inhalation flow
10512921, May 09 2016 Funai Electric Co., Ltd.; FUNAI ELECTRIC CO , LTD Maintenance apparatus for vaporizing device
10517507, Jul 11 2011 OTSUKA PHARMACEUTICAL CO , LTD Communication system with enhanced partial power source and method of manufacturing same
10542909, Apr 28 2005 Proteus Digital Health, Inc. Communication system with partial power source
10561806, Oct 02 2014 MannKind Corporation Mouthpiece cover for an inhaler
10573161, Aug 28 2013 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
10575137, Sep 28 2015 Nicoventures Trading Limited Vaping heat map system and method for electronic vapor provision systems
10588544, Apr 28 2009 OTSUKA PHARMACEUTICAL CO , LTD Highly reliable ingestible event markers and methods for using the same
10603450, Mar 03 2014 ADHERIUM NZ LIMITED Compliance monitor for a dry powder medicament delivery device
10610128, Apr 28 2005 Proteus Digital Health, Inc. Pharma-informatics system
10625034, Apr 01 2011 MannKind Corporation Blister package for pharmaceutical cartridges
10668230, May 09 2002 SAVILE THERAPEUTICS, INC Particle dispersion chamber for nasal nebulizer
10675421, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
10722664, Nov 13 2015 Manually actuatable inhaler
10751488, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
10797758, Jul 22 2016 OTSUKA PHARMACEUTICAL CO , LTD Electromagnetic sensing and detection of ingestible event markers
10828434, Aug 30 2013 ADHERIUM NZ LIMITED Compliance monitor for a medicament inhaler
10850050, May 19 2016 Trudell Medical International Smart valved holding chamber
10874149, Oct 19 2012 Nicoventures Trading Limited Electronic inhalation device
10881818, Jul 08 2016 Trudell Medical International Smart oscillating positive expiratory pressure device
10894142, Mar 24 2016 Trudell Medical International Respiratory care system with electronic indicator
10945972, May 03 2002 Nektar Therapeutics Particulate materials
10950149, Aug 01 2006 Trudell Medical International Dispensing device
10989803, Aug 21 2017 Massachusetts Institute of Technology Security protocol for motion tracking systems
11051543, Jul 21 2015 OTSUKA PHARMACEUTICAL CO , LTD Alginate on adhesive bilayer laminate film
11071836, Mar 29 2018 RECIPROCAL LABS CORPORATION D B A PROPELLER HEALTH Single dose inhaler monitoring attachment
11149123, Jan 29 2013 OTSUKA PHARMACEUTICAL CO , LTD Highly-swellable polymeric films and compositions comprising the same
11173290, Apr 07 2010 OTSUKA PHARMACEUTICAL CO , LTD Miniature ingestible device
11229378, Jul 11 2011 OTSUKA PHARMACEUTICAL CO , LTD Communication system with enhanced partial power source and method of manufacturing same
11253661, Jun 25 2012 GECKO HEALTH INNOVATIONS, INC Devices, systems, and methods for adherence monitoring and patient interaction
11278677, Feb 19 2015 Sanofi-Aventis Deutschland GmbH Data collection device for attachment to an injection device
11395890, Jun 04 2018 Trudell Medical International Smart valved holding chamber
11424026, Mar 24 2011 Sanofi-Aventis Deutschland GmbH Device and method for detecting an actuation action performable with a medical device
11439762, Jun 09 2015 Sanofi-Aventis Deutschland GmbH Data collection apparatus for attachment to an injection device
11446127, Aug 05 2013 MannKind Corporation Insufflation apparatus and methods
11476952, Apr 28 2005 OTSUKA PHARMACEUTICAL CO , LTD Pharma-informatics system
11478591, May 19 2016 MannKind Corporation Apparatus, system and method for detecting and monitoring inhalations
11497867, Dec 09 2016 Trudell Medical International Smart nebulizer
11504511, Nov 22 2010 OTSUKA PHARMACEUTICAL CO , LTD Ingestible device with pharmaceutical product
11511047, Jun 09 2015 Sanofi-Aventis Deutschland GmbH Data collection apparatus for attachment to an injection device
11529071, Oct 26 2016 OTSUKA PHARMACEUTICAL CO , LTD Methods for manufacturing capsules with ingestible event markers
11666801, Jan 04 2018 Trudell Medical International Smart oscillating positive expiratory pressure device
11701482, Oct 19 2012 Nicoventures Trading Limited Electronic inhalation device
11712175, Aug 27 2019 Trudell Medical International Smart oscillating positive expiratory pressure device with feedback indicia
11730891, Jun 09 2015 Sanofi-Aventis Deutschland GmbH Data collection apparatus for attachment to an injection device
11793419, Oct 26 2016 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
11793952, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
11839716, Jul 08 2016 Trudell Medical International Smart oscillating positive expiratory pressure device
11850355, Jun 04 2018 Trudell Medical International Smart valved holding chamber
11862331, Mar 24 2011 Sanofi-Aventis Deutschland GmbH Device and method for detecting an actuation action performable with a medical device
5419315, Jan 29 1993 Aradigm Corporation Intrapulmonary delivery of hormones
5487378, Dec 17 1990 Minnesota Mining and Manufacturing Company Inhaler
5505192, Nov 12 1993 MEDITRACK PRODUCTS, LLC Dispenser monitoring system
5507278, Nov 18 1994 Tongue-guard for inhaler
5649554, Oct 16 1995 Philip Morris Incorporated Electrical lighter with a rotatable tobacco supply
5673685, May 29 1992 PULMOTEC GMBH Device for generating inhalable active substance particles
5687710, Jun 01 1995 Merck Sharp & Dohme Corp Inhaler for powdered medications having spiral deagglomeration chamber
5740792, Jun 01 1995 Merck Sharp & Dohme Corp Inhaler for powdered medications with gear-teeth counter assembly
5775320, Jul 02 1991 Novartis Pharma AG Method and device for delivering aerosolized medicaments
5780014, Apr 14 1995 Novartis Pharma AG Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
5839429, Mar 25 1994 Astra Aktiebolag Method and apparatus in connection with an inhaler
5993783, Mar 13 1996 Novartis Pharma AG Method and apparatus for pulmonary administration of dry powder α1-antitrypsin
5996577, Aug 11 1995 Hitachi, LTD Medicine administering apparatus
5997848, Mar 07 1994 Novartis Pharma AG Methods and compositions for pulmonary delivery of insulin
6051256, Mar 07 1994 Novartis Pharma AG Dispersible macromolecule compositions and methods for their preparation and use
6076521, Nov 29 1994 Astra Aktiebolag Dose indicating device
6082358, May 05 1998 Trudell Medical International Indicating device for aerosol container
6102035, Aug 10 1995 Astra Aktiebolag Inhaler
6116239, Aug 07 1997 SLUTSKY, ART; ZAMEL, NOE; VOLGYESI, GEORGE Inhalation device
6119684, Jun 29 1994 Boehringer Ingelheim KG Aerosol inhaler
6138668, Jul 02 1991 Novartis Pharma AG Method and device for delivering aerosolized medicaments
6142145, Mar 14 1997 Astra Aktiebolag Inhalation device
6142146, Jun 12 1998 MICRODOSE THERAPEUTX, INC Inhalation device
6142339, Jan 16 1998 Trudell Medical International Aerosol dispensing device
6152130, Jun 12 1998 MICRODOSE THERAPEUTX, INC Inhalation device with acoustic control
6161724, Jan 16 1998 Trudell Medical International Indicating device
6182655, Dec 07 1995 Jagotec AG Inhaler for multiple dosed administration of a pharmacological dry powder
6273085, Mar 20 1997 APTAR FRANCE SAS Dry powder inhaler
6321747, Jan 08 1997 SmithKline Beecham Corporation Inhalation device
6325061, Mar 30 1998 Astra Aktiebolag Inhalation device
6328037, May 05 1998 Trudell Medical International Indicating device for aerosol container
6336453, Apr 30 1999 Trudell Medical International Indicating device for aerosol container
6341605, Feb 05 1998 Hitachi, LTD Inhalant medicator
6358058, Jan 30 1998 1263152 ONTARIO INC Aerosol dispensing inhaler training device
6390088, Dec 13 1993 Boehringer Ingelheim KG Aerosol inhaler
6423344, Mar 07 1994 Novartis Pharma AG Dispersible macromolecule compositions and methods for their preparation and use
6435372, Jan 16 1998 Trudell Medical International Delivery system for a medicament and method for the assembly thereof
6446626, Mar 14 1997 Astra Aktiebolag Inhalation device
6484715, Jul 14 1998 APTAR RADOLFZELL GMBH Media dispenser
6484717, Mar 14 1997 Astra Aktiebolag Inhalation device
6509006, Jul 08 1992 Novartis Pharma AG Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
6543448, Sep 21 1994 Novartis Pharma AG Apparatus and methods for dispersing dry powder medicaments
6546929, Jun 04 1998 Novartis Pharma AG Dry powder dispersing apparatus and methods for their use
6561384, Jan 16 1998 Trudell Medical International Medicament dispensing device and method for the use thereof
6575160, Aug 07 1997 Art, Slutsky; Noe, Zamel; George, Volgyesi Inhalation device
6582728, Jul 08 1992 Novartis Pharma AG Spray drying of macromolecules to produce inhaleable dry powders
6592904, Mar 07 1994 Novartis Pharma AG Dispersible macromolecule compositions and methods for their preparation and use
6655380, Mar 14 1997 AstraZeneca AB Inhalation device
6681767, Jul 02 1991 Novartis Pharma AG Method and device for delivering aerosolized medicaments
6685967, Mar 07 1994 Novartis Pharma AG Methods and compositions for pulmonary delivery of insulin
6729330, May 05 1998 Trudell Medical International Indicating device for aerosol container
6737045, Mar 07 1994 Novartis Pharma AG Methods and compositions for the pulmonary delivery insulin
6745760, May 15 2001 Trudell Medical International Medicament applicator
6761161, May 05 1998 Trudell Medical International Indicating device
6797258, Jul 08 1992 Novartis Pharma AG Compositions and methods for the pulmonary delivery of aerosolized macromolecules
6830046, Apr 29 2002 HEWLETT-PACKARD DEVELOPMENT COMPANY, L P Metered dose inhaler
6886557, Oct 31 2002 HEWLETT-PACKARD DEVELOPMENT COMPANY, L P Inhalation device and method for delivering variable amounts of different components
6901929, Jun 04 1998 Novartis Pharma AG Dry powder dispersing apparatus and methods for their use
6921527, Jul 08 1992 Novartis Pharma AG Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
6926002, May 05 1998 Trudell Medical International Indicating device
6938796, Jan 16 1998 Trudell Medical International Indicating device
6953039, May 05 1998 Trudell Medical International Medicament dispensing device
6997349, Jan 16 1998 Trudell Medical International Indicating device
7004164, Mar 21 2002 Trudell Medical International Indicating device for aerosol container
7097827, Apr 14 1995 Novartis AG Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments
7100530, Dec 15 2003 Trudell Medical International Dose indicating device
7131441, Dec 07 1995 Jagotec AG Inhaler for multiple dosed administration of a pharmacological dry powder
7138141, Mar 07 1994 Novartis AG Dispersible macromolecule compositions and methods for their preparation and use
7275534, Jan 31 2003 HEWLETT-PACKARD COMPANY, L P Medicament ejector with ejection port servicing
7278419, Jan 29 1993 Aradigm Corporation Method for treating diabetes mellitus in a patient
7341057, May 05 1998 Trudell Medical International Indicating device
7422013, Jun 04 1998 Novartis Pharma AG Dry powder dispersing apparatus and methods for their use
7448375, Jan 29 1993 Aradigm Corporation Method of treating diabetes mellitus in a patient
7467630, Feb 11 2004 Hewlett-Packard Development Company, L.P. Medicament dispenser
7481213, Feb 11 2004 Hewlett-Packard Development Company, L.P. Medicament dispenser
7516738, May 05 1998 Trudell Medical International Indicating device
7521069, Mar 07 1994 Novartis AG Methods and compositions for pulmonary delivery of insulin
7530352, Dec 07 2004 Hewlett-Packard Development Company, L.P. Inhalation device and method for delivering variable amounts of different components
7543582, Sep 20 2004 Trudell Medical International Dose indicating device with display elements attached to container
7568481, May 05 1998 Trudell Medical International Indicating device
7575130, Jan 16 1998 Trudell Medical International Indicating device
7582284, Apr 17 2002 Nektar Therapeutics Particulate materials
7584712, Dec 15 2003 Trudell Medical International Dose indicating device
7597102, Mar 21 2002 Trudell Medical International Indicating device for aerosol container
7621273, Oct 28 2003 Trudell Medical International Indicating device with warning dosage indicator
7650883, May 05 1998 Trudell Medical International Dispensing device
7726303, Feb 25 2003 HEWLETT-PACKARD DEVELOPMENT COMPANY, L P Controlled medicament ejection
7743945, Jan 20 2005 Trudell Medical International Dispensing device
7757688, May 05 1998 Trudell Medical International Dispensing device
7886934, Jan 20 2005 Trudell Medical International Dispensing device
7907477, Mar 02 2007 Bottle cap medication timer
7984826, Jan 16 1998 Trudell Medical International Indicating device
7994197, Feb 11 2007 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
8074594, Dec 15 2003 Trudell Medical International Dose indicating device
8074643, May 05 1998 Trudell Medical International Dispensing device
8079362, Sep 20 2004 Trudell Medical International Method for displaying dosage indicia
8080236, Apr 17 2002 Nektar Therapeutics Particulate materials
8082873, May 05 2008 Trudell Medical International Drive mechanism for an indicating device
8087548, May 14 2008 S C JOHNSON & SON, INC Spray products with particles and improved valve for inverted dispensing without clogging
8119639, Feb 11 2007 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
8141550, Aug 01 2006 Trudell Medical International Dispensing device
8148377, Feb 11 2007 MAP PHARMACEUTICALS, INC Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
8157128, Jan 16 1998 Trudell Medical International Indicating device
8161969, Jun 04 1998 Novartis AG Dry powder dispersing apparatus and methods for their use
8173168, Mar 07 1994 Novartis Pharma AG Dispersible macromolecule compositions and methods for their preparation and use
8181591, May 23 2008 Trudell Medical International Domed actuator for indicating device
8261738, Jul 24 2007 RESPIRONICS RESPIRATORY DRUG DELIVERY UK LTD Apparatus and method for maintaining consistency for aerosol drug delivery treatments
8273330, May 03 2002 Nektar Therapeutics Particulate materials
8327847, Mar 21 2002 Trudell Medical International Indicating device for aerosol container
8332020, Feb 01 2010 PROTEUS DIGITAL HEALTH, INC Two-wrist data gathering system
8337895, Jun 30 2000 Novartis AG Spray drying process control of drying kinetics
8419638, Nov 19 2007 PROTEUS DIGITAL HEALTH, INC Body-associated fluid transport structure evaluation devices
8470301, Apr 17 2002 Nektar Therapeutics Particulate materials
8505773, Jan 16 1998 Trudell Medical International Indicating device
8578934, Oct 28 2003 Trudell Medical International Indicating device with warning dosage indicator
8596265, Oct 22 2008 Trudell Medical International Modular aerosol delivery system
8662075, May 05 1998 Trudell Medical International Dispensing device
8802149, Dec 31 1996 Novartis Pharma AG Systems and processes for spray drying hydrophobic and hydrophilic components
8807131, Jun 18 2013 RESPIRI LIMITED Compliance monitoring for asthma inhalers
8828359, Apr 17 2002 Nektar Therapeutics Particulate materials
8869735, Dec 15 2003 Trudell Medical International, Inc. Dose indicating device
8944285, Jan 16 1998 Trudell Medical International Indicating device
8973784, Jan 20 2005 Trudell Medical International Dispensing device
9008761, Feb 01 2010 Proteus Digital Health, Inc. Two-wrist data gathering system
9014779, Feb 01 2010 PROTEUS DIGITAL HEALTH, INC Data gathering system
9032953, Oct 22 2008 Trudell Medical International Modular aerosol delivery system
9035765, Aug 28 2013 GECKO HEALTH INNOVATIONS, INC Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
9084566, Jul 07 2006 OTSUKA PHARMACEUTICAL CO , LTD Smart parenteral administration system
9107806, Nov 22 2010 PROTEUS DIGITAL HEALTH, INC Ingestible device with pharmaceutical product
9119554, Apr 28 2005 OTSUKA PHARMACEUTICAL CO , LTD Pharma-informatics system
9119918, Mar 25 2009 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
9125979, Oct 25 2007 PROTEUS DIGITAL HEALTH, INC Fluid transfer port information system
9161707, Jul 11 2011 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
9168343, May 05 1998 Trudell Medical International Dispensing device
9179691, Dec 14 2007 AERODESIGNS, INC Delivering aerosolizable food products
9192675, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9220687, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9233159, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9241903, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
9242057, Oct 22 2008 Trudell Medical International Modular aerosol delivery system
9265901, Aug 01 2006 Trudell Medical International Dispensing device
9268909, Oct 18 2012 OTSUKA PHARMACEUTICAL CO , LTD Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
9270025, Mar 09 2007 PROTEUS DIGITAL HEALTH, INC In-body device having deployable antenna
9271897, Jul 23 2012 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
9283193, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9320455, Apr 28 2009 OTSUKA PHARMACEUTICAL CO , LTD Highly reliable ingestible event markers and methods for using the same
9339615, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9346766, Aug 20 2004 MannKind Corporation Catalysis of diketopiperazine synthesis
9352106, May 09 2002 SAVILE THERAPEUTICS, INC Particle dispersion device for nasal delivery
9352107, Jan 07 2010 Koninklijke Philips Electronics N V Respiratory drug delivery apparatus including a feedback and compliance device
9364436, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
9364619, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
9415010, Aug 13 2008 Proteus Digital Health, Inc. Ingestible circuitry
9439582, Jul 11 2011 Proteus Digital Health, Inc. Communication system with remote activation
9446001, Sep 14 2005 MannKind Corporation Increasing drug affinity for crystalline microparticle surfaces
9446133, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9446209, Sep 07 2011 CONCENTRX PHARMACEUTICALS, INC Dry powder inhalation device
9511198, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9555200, Mar 15 2011 Novartis AG Inhaler
9555202, Aug 25 2008 Koninklijke Philips Electronics N V Respiratory drug delivery apparatus which provides audio instructions
9572943, Sep 28 2001 SAVILE THERAPEUTICS, INC Particle dispersion device for nasal delivery
9597487, Apr 07 2010 PROTEUS DIGITAL HEALTH, INC Miniature ingestible device
9610351, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9616060, Apr 17 2002 Nektar Therapeutics Particulate materials
9630930, Jun 12 2009 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
9649066, Sep 21 2009 Proteus Digital Health, Inc. Communication system with partial power source
9649455, Jan 16 1998 Trudell Medical International Indicating device
9655850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9656032, Jan 20 2005 Trudell Medical International Dispensing device
9662461, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9675674, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
9681842, Apr 28 2005 Proteus Digital Health, Inc. Pharma-informatics system
9700529, May 03 2002 Nektar Therapeutics Particulate materials
9700690, Mar 20 2002 MannKind Corporation Inhalation apparatus
9706944, Nov 03 2009 MannKind Corporation Apparatus and method for simulating inhalation efforts
9717689, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9728068, Aug 28 2013 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
9756874, Jan 21 2014 OTSUKA PHARMACEUTICAL CO , LTD Masticable ingestible product and communication system therefor
9796576, Aug 30 2013 OTSUKA PHARMACEUTICAL CO , LTD Container with electronically controlled interlock
9796688, Aug 20 2004 MannKind Corporation Catalysis of diketopiperazine synthesis
9801925, Jun 29 1999 MannKind Corporation Potentiation of glucose elimination
9802012, Jul 12 2012 MannKind Corporation Dry powder drug delivery system and methods
9833451, Feb 11 2007 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
9925144, Jul 18 2013 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
9943571, Aug 11 2008 MannKind Corporation Use of ultrarapid acting insulin
9962107, Jul 11 2011 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
9968748, Oct 28 2003 Trudell Medical International Indicating device with warning dosage indicator
9983108, Mar 11 2009 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
D365876, Jun 16 1993 Fisons plc Medicament inhaler
D377686, Mar 25 1994 Astra Aktiebolag Training device for inhaler
D417732, Mar 30 1998 Astra Aktiebolag Dry powder inhaler with cover
D417912, Mar 30 1998 Astra Aktiebolag Dry powder inhaler with cover
D439534, May 05 1998 Trudell Medical International Indicating device
D441446, Mar 30 1998 Astra Aktiebolag Dry powder inhaler with cover
D456292, May 05 1998 Trudell Medical International Indicating device
D469527, Dec 07 1995 Jagotec AG Pharmacological inhaler
D910163, Jan 03 2019 Trudell Medical International Oscillating positive expiratory pressure device, adapter and control module assembly
Patent Priority Assignee Title
2587215,
3807400,
4109656, Feb 07 1977 Liebel-Flarsheim Company Apparatus for use with insufflators
4291688, Jan 11 1979 Schering Corp. Inhalation device
4484577, Apr 22 1980 Key Pharmaceuticals, Inc. Drug delivery method and inhalation device therefor
4677975, Oct 16 1984 UNIVERSITY OF AUCKLAND THE Method of dispensing and/or a dispenser
4817822, Apr 25 1986 GLAXO GROUP LIMITED, CLARGES HOUSE 6 12 CLARGES STREET, LONDON W1Y 8DH, ENGLAND Indicating device
4830022, Jul 27 1987 Medical Engineering and Development, Inc. Animal monitoring system
4984158, Oct 14 1988 SIERRA BIOTECHNOLOGY COMPANY, L C Metered dose inhaler biofeedback training and evaluation system
5020527, Feb 20 1990 IDEAL IDEAS, INC Inhaler device with counter/timer means
5035237, Jul 30 1985 Devices for administering medicaments to patients
5042467, Jan 03 1989 Trudell Medical Medication inhaler with fitting having a sonic signalling device
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jul 06 1993Aktiebolaget Draco(assignment on the face of the patent)
Date Maintenance Fee Events
Jan 12 1998M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Dec 28 2001M184: Payment of Maintenance Fee, 8th Year, Large Entity.
Dec 28 2005M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Jul 26 19974 years fee payment window open
Jan 26 19986 months grace period start (w surcharge)
Jul 26 1998patent expiry (for year 4)
Jul 26 20002 years to revive unintentionally abandoned end. (for year 4)
Jul 26 20018 years fee payment window open
Jan 26 20026 months grace period start (w surcharge)
Jul 26 2002patent expiry (for year 8)
Jul 26 20042 years to revive unintentionally abandoned end. (for year 8)
Jul 26 200512 years fee payment window open
Jan 26 20066 months grace period start (w surcharge)
Jul 26 2006patent expiry (for year 12)
Jul 26 20082 years to revive unintentionally abandoned end. (for year 12)